Health Conditions

View All

Latest Updates Across All Health Conditions

Nutrition & Fitness

View All

The Latest News from All Areas of Nutrition & Fitness

Wellness & Self-Care

View All

The Latest News from All Areas of Nutrition & Fitness

Innovations

View All

The Latest News from All Areas of Innovation

MORE NEWS

View All

Could indigo light help fight the growing “myopia boom?”

Obesity treatment should focus on better health, not weight loss alone

More data, more answers? A 1.9 million-person health study shows why scale has limits

APOE genotype helps p-tau217 predict who may develop cognitive impairment sooner

A study of ayahuasca users found a mental health pattern researchers cannot yet explain

Cockroaches have a reputation for surviving almost anything, but this diet proved deadly

A large US study found no overall link between fluoride in pregnancy and children’s behavior

NT-proBNP blood marker may help identify older adults at higher risk of heart disease

Subcutaneous tarlatamab exhibits low toxicity rates in phase 1b trial

Phase 2 study highlights flexible dosing options for tarlatamab in relapsed SCLC

MD Anderson trial challenges local consolidative therapy paradigm in NSCLC

Neoadjuvant atezolizumab addition quadruples pathological responses in resectable lung tumors

The Latest News from All Areas of News

Could indigo light help fight the growing “myopia boom?”

Obesity treatment should focus on better health, not weight loss alone

More data, more answers? A 1.9 million-person health study shows why scale has limits

APOE genotype helps p-tau217 predict who may develop cognitive impairment sooner

A study of ayahuasca users found a mental health pattern researchers cannot yet explain

Cockroaches have a reputation for surviving almost anything, but this diet proved deadly

A large US study found no overall link between fluoride in pregnancy and children’s behavior

NT-proBNP blood marker may help identify older adults at higher risk of heart disease

Subcutaneous tarlatamab exhibits low toxicity rates in phase 1b trial

Phase 2 study highlights flexible dosing options for tarlatamab in relapsed SCLC

MD Anderson trial challenges local consolidative therapy paradigm in NSCLC

Neoadjuvant atezolizumab addition quadruples pathological responses in resectable lung tumors